KEY FEATURES
| Full Name | Tachykinin Receptor 1 |
|---|---|
| Synonym | NK1R; SPR; NKIR; TAC1R; Neurokinin 1 Receptor; Substance P Receptor |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human TACR1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TACR1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human TACR1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human TACR1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TACR1. You can calculate the concentration of Human TACR1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human TACR1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.02 | 1.71 | 7.91 | 0.99 | 1.72 | 7.21 |
| Standard deviation | 0.07 | 0.07 | 0.24 | 0.06 | 0.1 | 0.28 |
| CV(%) | 6.89 | 4.34 | 3.03 | 5.7 | 5.98 | 3.88 |
RECOVERY
The recovery of Human TACR1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 87-101 | 93 |
| EDTA plasma (n=8) | 84-95 | 90 |
| Cell culture media (n=8) | 88-103 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human TACR1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with SP-R ELISA Kits
| NTS ELISA Kit | publications with SP-R and NTS |
| CCK ELISA Kit | publications with SP-R and CCK |
| TAC1 ELISA Kit | publications with SP-R and TAC1 |
| TRH ELISA Kit | publications with SP-R and TRH |
| GRP ELISA Kit | publications with SP-R and GRP |
| TAC3 ELISA Kit | publications with SP-R and TAC3 |
| GRK5 ELISA Kit | publications with SP-R and GRK5 |
| ADRBK1 ELISA Kit | publications with SP-R and ADRBK1 |
Pathways associated with SP-R ELISA Kit
| Calcium Signaling Pathway | Calcium Signaling Pathway |
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| G Alpha (q) Signalling Events Pathway | G Alpha (q) Signalling Events Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
| GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
| Gastrin-CREB Signalling Pathway Via PKC And MAPK | Gastrin-CREB Signalling Pathway Via PKC And MAPK |
| Measles Pathway | Measles Pathway |
| Neuroactive Ligand-receptor Interaction Pathway | Neuroactive Ligand-receptor Interaction Pathway |
Diseases associated with SP-R ELISA Kit
| Pain | publications with SP-R and Pain |
| Inflammation | publications with SP-R and Inflammation |
| Vomiting | publications with SP-R and Vomiting |
| Neoplasms | publications with SP-R and Neoplasms |
| Neurogenic Inflammation | publications with SP-R and Neurogenic Inflammation |
| Hyperalgesia | publications with SP-R and Hyperalgesia |
| Brain Diseases | publications with SP-R and Brain Diseases |
| Edema | publications with SP-R and Edema |
| Lung Diseases | publications with SP-R and Lung Diseases |
| Necrosis | publications with SP-R and Necrosis |
Organs/Tissues associated with SP-R ELISA Kit
| Brain | publications with SP-R and Brain |
| Trachea | publications with SP-R and Trachea |
| Pancreas | publications with SP-R and Pancreas |
| Eye | publications with SP-R and Eye |
| Spleen | publications with SP-R and Spleen |
| Connective Tissue | publications with SP-R and Connective Tissue |
| Uterus | publications with SP-R and Uterus |
| Embryonic Tissue | publications with SP-R and Embryonic Tissue |
| Adipose Tissue | publications with SP-R and Adipose Tissue |